Research Article
Knowledge of Latin American Obstetricians and Gynecologists regarding Heavy Menstrual Bleeding
Table 2
Answers provided by the OBGYNs regarding some therapeutic aspects of heavy menstrual bleeding (HMB).
| | Age (%) | Gender (%) | Working in (%) | | ≤49 ys | ≥50 ys | Female | Male | Public sector | Private/public sector |
| What is the proportion of women with improvement of HMB with a COC with EE? (n = 203) | | | | | | | <50% | 98.0 | 79.4 | 87.1 | 89.7 | 86.7 | 90.0 | Up to 80% | 2.0 | 20.6 | 12.9 | 10.3 | 13.3 | 10.0 | What is the proportion of women with improvement of HMB with a COC with estradiol Val/DNG? (n = 199) | | | | | | | 30–40% | 27.7 | 39.0 | 27.8 | 37.7 | 38.8 | 29.3 | 41–79% | 41.2 | 28.4 | 28.3 | 35.2 | 32.3 | 33.6 | >80% | 31.1 | 32.6 | 43.9 | 27.1 | 28.9 | 37.1 | What is the proportion of women with improvement of HMB with an LNG-IUS at the end of the first year of use? (n = 201) | | | | | | | 30–79% | 75.6 | 75.6 | 82.9 | 70.2 | 81.6 | 71.7 | >80% | 24.4 | 24.4 | 17.1 | 29.8 | 18.4 | 28.3 |
|
|
OBGYNs: obstetricians and gynecologists; COC: combined oral contraceptive; EE: ethynyl estradiol; LNG-IUS: levonorgestrel-releasing intrauterine system.
|